Kevin R. King

5.8k total citations · 2 hit papers
61 papers, 3.3k citations indexed

About

Kevin R. King is a scholar working on Molecular Biology, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin R. King has authored 61 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Biomedical Engineering and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin R. King's work include 3D Printing in Biomedical Research (12 papers), Protein purification and stability (5 papers) and Cardiac Fibrosis and Remodeling (5 papers). Kevin R. King is often cited by papers focused on 3D Printing in Biomedical Research (12 papers), Protein purification and stability (5 papers) and Cardiac Fibrosis and Remodeling (5 papers). Kevin R. King collaborates with scholars based in United States, United Kingdom and Germany. Kevin R. King's co-authors include Sandeep Nema, Satish Kumar Singh, Martin L. Yarmush, Wei Wang, David L. Zeng, Jeffrey T. Borenstein, Joseph P. Vacanti, Mehmet Toner, Mohammad R. K. Mofrad and Eli J. Weinberg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Kevin R. King

55 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody Structure, Instability, and Formulation

2006 735 citations Wei Wang, Satish Kumar Singh et al. Journal of Pharmaceutical Sciences profile →
IRF3 and type I interferons fuel a fatal response to myocardial infarction

2017 412 citations Kevin R. King, Aaron D. Aguirre et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin R. King United States	26	1.8k	1.0k	641	628	284	61	3.3k
Sriram Neelamegham United States	39	2.0k 1.1×	412 0.4×	1.0k 1.6×	343 0.5×	467 1.6×	125	4.2k
Yohan Kim United States	35	1.1k 0.6×	1.2k 1.2×	512 0.8×	576 0.9×	396 1.4×	141	3.8k
Jung‐Joon Min South Korea	41	1.3k 0.8×	2.6k 2.5×	542 0.8×	1.0k 1.6×	336 1.2×	193	5.9k
Eric L. Kaijzel Netherlands	31	711 0.4×	676 0.7×	534 0.8×	385 0.6×	223 0.8×	69	2.5k
Ivo Que Netherlands	34	1.5k 0.9×	954 0.9×	430 0.7×	473 0.8×	261 0.9×	85	4.0k
Xiaoling Lü China	32	1.4k 0.8×	588 0.6×	684 1.1×	295 0.5×	181 0.6×	206	3.2k
Louis van Bloois Netherlands	33	1.6k 0.9×	607 0.6×	908 1.4×	424 0.7×	221 0.8×	59	3.5k
Wei‐Chou Lin Taiwan	33	958 0.5×	478 0.5×	257 0.4×	354 0.6×	747 2.6×	134	3.3k
Yun Wu United States	40	2.9k 1.7×	1.2k 1.1×	310 0.5×	213 0.3×	185 0.7×	113	5.1k
Rostyslav Bilyy Ukraine	29	1.7k 1.0×	563 0.5×	1.8k 2.8×	268 0.4×	160 0.6×	117	3.9k

Countries citing papers authored by Kevin R. King

Since Specialization

Citations

This map shows the geographic impact of Kevin R. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin R. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin R. King more than expected).

Fields of papers citing papers by Kevin R. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin R. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin R. King. The network helps show where Kevin R. King may publish in the future.

Co-authorship network of co-authors of Kevin R. King

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin R. King. A scholar is included among the top collaborators of Kevin R. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin R. King. Kevin R. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elder, George H., et al.. (2025). Implementation of geriatric clinical decision support in the emergency department for potentially inappropriate medications. Academic Emergency Medicine. 33(1). e70059–e70059.

Ninh, Van K., Michael Nguyen, Raymond Wang, et al.. (2025). Regional and cell specific bioactivity of injectable extracellular matrix biomaterials in myocardial infarction. Nature Communications. 16(1). 10387–10387.

Ninh, Van K., David Calcagno, Justin Yu, et al.. (2024). Spatially clustered type I interferon responses at injury borderzones. Nature. 633(8028). 174–181. 16 indexed citations

Yu, Justin, et al.. (2023). Single cell transcriptomics of bone marrow derived macrophages reveals Ccl5 as a biomarker of direct IFNAR-independent responses to DNA sensing. Frontiers in Immunology. 14. 1199730–1199730. 2 indexed citations

King, Kevin R., et al.. (2022). Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine. Circulation Heart Failure. 15(4). e009321–e009321. 9 indexed citations

Calcagno, David, Claire Zhang, Avinash Toomu, et al.. (2021). SiglecF(HI) Marks Late‐Stage Neutrophils of the Infarcted Heart: A Single‐Cell Transcriptomic Analysis of Neutrophil Diversification. Journal of the American Heart Association. 10(4). 59 indexed citations

Bhatia, Harpreet, Quan M. Bui, Kevin R. King, Anthony N. DeMaria, & Lori B. Daniels. (2021). Subclinical left ventricular dysfunction in COVID-19. IJC Heart & Vasculature. 34. 100770–100770. 23 indexed citations

Luther, Jay, Sanjoy K. Khan, Manish Gala, et al.. (2020). Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proceedings of the National Academy of Sciences. 117(21). 11667–11673. 69 indexed citations

Calcagno, David, Richard P Ng, Avinash Toomu, et al.. (2020). The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages. Science Immunology. 5(51). 70 indexed citations

10.

Boer, Emilia den, et al.. (2016). Volatile fatty acids as an added value from biowaste. Waste Management. 58. 62–69. 33 indexed citations

11.

Jayaraman, Murali, Patrick M. Buck, Arun Alphonse Ignatius, Kevin R. King, & Wei Wang. (2014). Agitation-induced aggregation and subvisible particulate formation in model proteins. European Journal of Pharmaceutics and Biopharmaceutics. 87(2). 299–309. 34 indexed citations

12.

Lewis, Heather, Mark C. Wilkinson, James T. Dalton, et al.. (2012). 1131 ACTIVE INJECTION DRUG USER'S CAN BE SUCCESSFULLY TREATED FOR HCV AND SIGNIFICANTLY REDUCE ILLICIT DRUG USE POST TREATMENT: REAL LIFE COHORT OF 152 PATIENTS. Journal of Hepatology. 56. S446–S446. 1 indexed citations

13.

Patel, Suraj J., Kevin R. King, Monica Casali, & Martin L. Yarmush. (2009). DNA-triggered innate immune responses are propagated by gap junction communication. Proceedings of the National Academy of Sciences. 106(31). 12867–12872. 53 indexed citations

14.

Wang, Wei, Satish Kumar Singh, David L. Zeng, Kevin R. King, & Sandeep Nema. (2006). Antibody Structure, Instability, and Formulation. Journal of Pharmaceutical Sciences. 96(1). 1–26. 735 indexed citations breakdown →

15.

King, Kevin R., et al.. (2006). A high-throughput microfluidic real-time gene expression living cell array. Lab on a Chip. 7(1). 77–85. 171 indexed citations

16.

Wieder, K J, et al.. (2005). Optimization of Reporter Cells for Expression Profiling in a Microfluidic Device. Biomedical Microdevices. 7(3). 213–222. 38 indexed citations

17.

Thompson, Deanna M., et al.. (2004). Dynamic Gene Expression Profiling Using a Microfabricated Living Cell Array. Analytical Chemistry. 76(14). 4098–4103. 130 indexed citations

18.

Borenstein, Jeffrey T., Wang L. Cheung, Mohammad R. K. Mofrad, et al.. (2004). Living three-dimensional micro fabricated constructs for the replacement of vital organ function. 2. 1754–1757. 11 indexed citations

19.

Moreland, Larry W., Kevin R. King, Michael Weisman, et al.. (2001). Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Research & Therapy. 3(4). 247–52. 41 indexed citations

20.

King, Kevin R., et al.. (2000). MEMS incandescent light source. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4134. 151–151. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact